Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
Classificação em ações #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Preço da ação
$0.0001
Última sincronização: 2026-07-17
Valor de mercado
$981.00
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Omnimmune Holdings, Inc. (OMMH)

Categoria

Rácio P/B de Omnimmune Holdings, Inc. (OMMH)
Rácio P/B em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da Omnimmune Holdings, Inc., o rácio P/B atual (TTM) é 0. No final de 2026, o rácio P/B era 0.
Histórico do rácio P/B da Omnimmune Holdings, Inc. de 2026 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
6.2613 -
US
6.3483 -
NL
- -
CH
3.634 -
BE
- -
KR